Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A temporary NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” was removed from the page.
    Difference
    1%
    Check dated 2026-11-08T04:49:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0 while the study record continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:55:18.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says “Super Intelligence” is replacing “Artificial Intelligence” in some agency content during the transition. It appears above the page’s 403 error for the study record.
    Difference
    1%
    Check dated 2026-10-25T01:48:04.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:36:53.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:08:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A 403 Forbidden error is now displayed, and the page’s study content and navigation are no longer visible.
    Difference
    17%
    Check dated 2026-09-20T01:06:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.